Autolus Therapeutics Plc
(NASDAQ) AUTL
Autolus Therapeutics Plc Financials at a Glance
Market Cap
$428.51M
Revenue (TTM)
$92.59M
Net Income (TTM)
-$288.83M
EPS (TTM)
-$1.09
P/E Ratio
-1.48
Dividend
$0.00
Beta (Volatility)
1.15 (Average)
Dividend
$0.00
Beta (Volatility)
1.15 (Average)
Price
$1.64
Volume
30,372
Open
$1.63
Price
$1.64
Volume
30,372
Open
$1.63
Previous Close
$1.64
Daily Range
$1.61 - $1.66
52-Week Range
$1.18 - $2.70
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
1.15 (Average)
Price
$1.64
Volume
30,372
Open
$1.63
Previous Close
$1.64
Daily Range
$1.61 - $1.66
52-Week Range
$1.18 - $2.70
Estimated Earnings Date
Aug 11, 2026
AUTL News
AUTL: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Autolus Therapeutics Plc
Industry
Biotechnology
Sector
Health CareEmployees
752
CEO
Christian Martin Itin, PhD
Website
www.autolus.comHeadquarters
London, W12 7FP, GB
AUTL Financials
Key Financial Metrics (TTM)
Gross Margin
-11.19%
Operating Margin
-285.90%
Net Income Margin
-311.95%
Return on Equity
-128.53%
Return on Capital
-53.13%
Return on Assets
-54.80%
Earnings Yield
-67.57%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$428.51M
Shares Outstanding
266.16M
Volume
30.37K
Avg. Volume
1.51M
Financials (TTM)
Gross Profit
-$10.36M
Operating Income
-$264.71M
EBITDA
-$230.80M
Operating Cash Flow
-$273.32M
Capital Expenditure
-$18.20M
Free Cash Flow
-$291.52M
Cash & ST Invst.
$229.43M
Total Debt
$79.96M
Autolus Therapeutics Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$26.22M
+191.9%
Gross Profit
$1.65M
+118.4%
Gross Margin
6.29%
N/A
Market Cap
$428.51M
N/A
Market Cap/Employee
$662.30K
N/A
Employees
647
N/A
Net Income
-$71.60M
-2.0%
EBITDA
-$56.94M
-2.6%
Quarterly Fundamentals
Total Cash
$229.43M
-55.6%
Total Debt
$79.96M
-74.3%
Accounts Receivable
$86.26M
+502.5%
Inventory
$33.23M
+126.9%
Long Term Debt
$76.90M
-75.0%
Short Term Debt
$3.06M
+2.9%
Return on Assets
-54.80%
N/A
Return on Invested Capital
-57.12%
N/A
Free Cash Flow
-$68.00M
+18.9%
Operating Cash Flow
-$65.32M
+13.6%